Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2020-05-15
|
| gptkbp:ATCCode |
L01EX19
|
| gptkbp:CASNumber |
1065146-93-0
|
| gptkbp:chemicalFormula |
C26H27F6N7O
|
| gptkbp:firstBook |
yes
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:ripretinib
|
| https://www.w3.org/2000/01/rdf-schema#label |
QINLOCK
|
| gptkbp:indication |
gptkb:gastrointestinal_stromal_tumor
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
Deciphera Pharmaceuticals
|
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:hand-foot_syndrome
nausea abdominal pain constipation fatigue alopecia myalgia |
| gptkbp:target |
gptkb:PDGFRA
gptkb:KIT |
| gptkbp:usedFor |
treatment of advanced GIST after prior kinase inhibitor therapies
|
| gptkbp:bfsParent |
gptkb:Zai_Lab
|
| gptkbp:bfsLayer |
7
|